TELEFLEX INC (TFX)

US8793691069 - Common Stock

209.07  +2.43 (+1.18%)

After market: 209.07 0 (0%)

Fundamental Rating

6

Taking everything into account, TFX scores 6 out of 10 in our fundamental rating. TFX was compared to 192 industry peers in the Health Care Equipment & Supplies industry. TFX gets an excellent profitability rating and is at the same time showing great financial health properties. TFX has a decent growth rate and is not valued too expensively.



8

1. Profitability

1.1 Basic Checks

TFX had positive earnings in the past year.
In the past year TFX had a positive cash flow from operations.
In the past 5 years TFX has always been profitable.
Each year in the past 5 years TFX had a positive operating cash flow.

1.2 Ratios

TFX's Return On Assets of 3.94% is fine compared to the rest of the industry. TFX outperforms 79.69% of its industry peers.
TFX has a better Return On Equity (6.55%) than 80.21% of its industry peers.
The Return On Invested Capital of TFX (6.89%) is better than 83.85% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for TFX is in line with the industry average of 8.46%.
The 3 year average ROIC (6.89%) for TFX is below the current ROIC(6.89%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.94%
ROE 6.55%
ROIC 6.89%
ROA(3y)5.68%
ROA(5y)5.81%
ROE(3y)9.99%
ROE(5y)11.1%
ROIC(3y)6.89%
ROIC(5y)6.63%

1.3 Margins

The Profit Margin of TFX (9.82%) is better than 83.33% of its industry peers.
In the last couple of years the Profit Margin of TFX has grown nicely.
Looking at the Operating Margin, with a value of 19.38%, TFX belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
TFX's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 55.70%, TFX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
TFX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.38%
PM (TTM) 9.82%
GM 55.7%
OM growth 3Y-1.24%
OM growth 5Y3%
PM growth 3Y-3.22%
PM growth 5Y7.87%
GM growth 3Y1.97%
GM growth 5Y-0.42%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TFX is destroying value.
The number of shares outstanding for TFX has been increased compared to 1 year ago.
The number of shares outstanding for TFX has been increased compared to 5 years ago.
The debt/assets ratio for TFX has been reduced compared to a year ago.

2.2 Solvency

TFX has an Altman-Z score of 3.53. This indicates that TFX is financially healthy and has little risk of bankruptcy at the moment.
TFX has a Altman-Z score of 3.53. This is in the better half of the industry: TFX outperforms 69.79% of its industry peers.
The Debt to FCF ratio of TFX is 4.09, which is a neutral value as it means it would take TFX, 4.09 years of fcf income to pay off all of its debts.
TFX's Debt to FCF ratio of 4.09 is amongst the best of the industry. TFX outperforms 83.85% of its industry peers.
TFX has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of TFX (0.37) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 4.09
Altman-Z 3.53
ROIC/WACC0.7
WACC9.84%

2.3 Liquidity

A Current Ratio of 2.51 indicates that TFX has no problem at all paying its short term obligations.
The Current ratio of TFX (2.51) is worse than 60.94% of its industry peers.
A Quick Ratio of 1.41 indicates that TFX should not have too much problems paying its short term obligations.
TFX has a Quick ratio of 1.41. This is in the lower half of the industry: TFX underperforms 68.23% of its industry peers.
The current and quick ratio evaluation for TFX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 1.41

4

3. Growth

3.1 Past

TFX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.79%.
Measured over the past 5 years, TFX shows a small growth in Earnings Per Share. The EPS has been growing by 6.41% on average per year.
The Revenue has been growing slightly by 4.93% in the past year.
Measured over the past years, TFX shows a small growth in Revenue. The Revenue has been growing by 3.97% on average per year.
EPS 1Y (TTM)2.79%
EPS 3Y8.21%
EPS 5Y6.41%
EPS Q2Q%3.88%
Revenue 1Y (TTM)4.93%
Revenue growth 3Y5.44%
Revenue growth 5Y3.97%
Sales Q2Q%3.78%

3.2 Future

Based on estimates for the next years, TFX will show a small growth in Earnings Per Share. The EPS will grow by 7.57% on average per year.
TFX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.02% yearly.
EPS Next Y2.76%
EPS Next 2Y6.49%
EPS Next 3Y7.71%
EPS Next 5Y7.57%
Revenue Next Year4.03%
Revenue Next 2Y4.79%
Revenue Next 3Y5.05%
Revenue Next 5Y5.02%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.33, the valuation of TFX can be described as correct.
91.67% of the companies in the same industry are more expensive than TFX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of TFX to the average of the S&P500 Index (28.05), we can say TFX is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 13.64, the valuation of TFX can be described as correct.
Based on the Price/Forward Earnings ratio, TFX is valued cheaper than 92.19% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.07. TFX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.33
Fwd PE 13.64

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TFX is valued cheaper than 89.58% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TFX is valued cheaply inside the industry as 88.54% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.93
EV/EBITDA 13.56

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TFX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.55
PEG (5Y)2.39
EPS Next 2Y6.49%
EPS Next 3Y7.71%

5

5. Dividend

5.1 Amount

TFX has a yearly dividend return of 0.66%, which is pretty low.
TFX's Dividend Yield is rather good when compared to the industry average which is at 1.74. TFX pays more dividend than 91.15% of the companies in the same industry.
With a Dividend Yield of 0.66, TFX pays less dividend than the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 0.66%

5.2 History

The dividend of TFX decreases each year by -0.06%.
TFX has been paying a dividend for at least 10 years, so it has a reliable track record.
TFX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.06%
Div Incr Years0
Div Non Decr Years19

5.3 Sustainability

TFX pays out 21.68% of its income as dividend. This is a sustainable payout ratio.
DP21.68%
EPS Next 2Y6.49%
EPS Next 3Y7.71%

TELEFLEX INC

NYSE:TFX (5/31/2024, 7:08:56 PM)

After market: 209.07 0 (0%)

209.07

+2.43 (+1.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.85B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.66%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15.33
Fwd PE 13.64
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)5.55
PEG (5Y)2.39
Profitability
Industry RankSector Rank
ROA 3.94%
ROE 6.55%
ROCE
ROIC
ROICexc
ROICexgc
OM 19.38%
PM (TTM) 9.82%
GM 55.7%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.51
Quick Ratio 1.41
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)2.79%
EPS 3Y8.21%
EPS 5Y
EPS Q2Q%
EPS Next Y2.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.93%
Revenue growth 3Y5.44%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y